产品
编 号：F471478
分子式：C35H46O20
分子量：786.73
分子式：C35H46O20
分子量：786.73
产品类型
规格
价格
是否有货
10mM*1mL in DMSO
询价
询价
5mg
256
In-stock
10mg
384
In-stock
50mg
询价
询价
结构图
CAS No: 82854-37-3
产品详情
生物活性：
Echinacoside, one of the phenylethanoids isolated from the stems of Cistanche deserticola, effectively inhibits Wnt/β-catenin signaling. Echinacoside elicits neuroprotection by activating Trk receptors and their downstream signal pathways. Antiosteoporotic activity.
体内研究：
紫锥菊苷 (30-270 mg/kg体重；口服；每天服用，持续 12 周) 显著逆转去势女性体重增加、血清羟脯氨酸 (HOP) 水平以及子宫湿重和骨密度 (BMD) 下降 (OVX) 大鼠。Animal Model:Fifty-six aged 6 months female Sprague-Dawley rats (OVX rat model)
Dosage:30, 90, 270 mg/kg body weight
Administration:p.o.; daily for 12 weeks
Result:The increases of body weight, serum hydroxyproline (HOP) levels, and the decreases of uterus wet weight and BMD were significantly reversed.
Echinacoside, one of the phenylethanoids isolated from the stems of Cistanche deserticola, effectively inhibits Wnt/β-catenin signaling. Echinacoside elicits neuroprotection by activating Trk receptors and their downstream signal pathways. Antiosteoporotic activity.
体内研究：
紫锥菊苷 (30-270 mg/kg体重；口服；每天服用，持续 12 周) 显著逆转去势女性体重增加、血清羟脯氨酸 (HOP) 水平以及子宫湿重和骨密度 (BMD) 下降 (OVX) 大鼠。Animal Model:Fifty-six aged 6 months female Sprague-Dawley rats (OVX rat model)
Dosage:30, 90, 270 mg/kg body weight
Administration:p.o.; daily for 12 weeks
Result:The increases of body weight, serum hydroxyproline (HOP) levels, and the decreases of uterus wet weight and BMD were significantly reversed.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备